139 related articles for article (PubMed ID: 2858818)
21. Effects of continuous and repetitive administration of a potent analog of GH-RH(1-30)-NH2 on the GH release in rats treated with monosodium glutamate.
Kovács M; Fáncsik A; Hrabovsky E; Mezö I; Teplán I; Flerkó B
J Neuroendocrinol; 1995 Sep; 7(9):703-12. PubMed ID: 8547948
[TBL] [Abstract][Full Text] [Related]
22. Effects of growth hormone-releasing factor and somatostatin on growth hormone secretion in hypophysial stalk-transected beef calves.
Plouzek CA; Molina JR; Hard DL; Vale WW; Rivier J; Trenkle A; Anderson LL
Proc Soc Exp Biol Med; 1988 Nov; 189(2):158-67. PubMed ID: 2904152
[TBL] [Abstract][Full Text] [Related]
23. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
[TBL] [Abstract][Full Text] [Related]
24. Pattern-dependent suppression of growth hormone (GH) pulsatility by ghrelin and GH-releasing peptide-6 in moderately GH-deficient rats.
Thompson NM; Davies JS; Mode A; Houston PA; Wells T
Endocrinology; 2003 Nov; 144(11):4859-67. PubMed ID: 12960077
[TBL] [Abstract][Full Text] [Related]
25. An evaluation of intravenous, subcutaneous, and in vitro activity of new agmatine analogs of growth hormone-releasing hormone hGH-RH (1-29)NH2.
Kovacs M; Gulyas J; Bajusz S; Schally AV
Life Sci; 1988; 42(1):27-35. PubMed ID: 2892105
[TBL] [Abstract][Full Text] [Related]
26. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone secretion in the guinea-pig.
Gabrielsson B; Fairhall KM; Robinson IC
J Endocrinol; 1990 Mar; 124(3):371-80. PubMed ID: 1970601
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the biological activities of authentic rat GRF(1-43)OH with the analogue rat GRF(1-29)NH2.
Kraicer J; French MB; Lussier BT; Moor BC; Brazlan P
Can J Physiol Pharmacol; 1991 Feb; 69(2):181-4. PubMed ID: 1829020
[TBL] [Abstract][Full Text] [Related]
29. The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats.
Badger TM; Millard WJ; McCormick GF; Bowers CY; Martin JB
Endocrinology; 1984 Oct; 115(4):1432-8. PubMed ID: 6148232
[TBL] [Abstract][Full Text] [Related]
30. Comparative study on the responses of plasma GH to synthetic GH-releasing factor and other stimulatory and inhibitory agents in patients with acromegaly.
Hanew K; Sato S; Sasaki A; Shimizu Y; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1985 Feb; 145(2):161-6. PubMed ID: 2859672
[TBL] [Abstract][Full Text] [Related]
31. The effect of glucose and free fatty acids on growth hormone (GH)-releasing factor-mediated GH secretion in rats.
Imaki T; Shibasaki T; Masuda A; Hotta M; Yamauchi N; Demura H; Shizume K; Wakabayashi I; Ling N
Endocrinology; 1986 Jun; 118(6):2390-4. PubMed ID: 2870916
[TBL] [Abstract][Full Text] [Related]
32. Regulation of release of somatotropin from in vitro cultures of bovine and porcine pituitary cells.
Glenn KC
Endocrinology; 1986 Jun; 118(6):2450-7. PubMed ID: 2422021
[TBL] [Abstract][Full Text] [Related]
33. Effects of continuous and repetitive administration of a potent analog of GH-RH(1-30)NH2 on the GH release in rats.
Kovács M; Fáncsik A; Mezö I; Teplán I; Flerkó B
Neuroendocrinology; 1994 Apr; 59(4):371-9. PubMed ID: 8202218
[TBL] [Abstract][Full Text] [Related]
34. An extremely sensitive in vitro model for elucidating structure-activity relationships of growth hormone-releasing factor analogs.
Heiman ML; Nekola MV; Murphy WA; Lance VA; Coy DH
Endocrinology; 1985 Jan; 116(1):410-5. PubMed ID: 2856874
[TBL] [Abstract][Full Text] [Related]
35. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors.
Goth MI; Lyons CE; Canny BJ; Thorner MO
Endocrinology; 1992 Feb; 130(2):939-44. PubMed ID: 1346381
[TBL] [Abstract][Full Text] [Related]
36. Effects of neonatal administration of monosodium glutamate on plasma growth hormone (GH) response to GH-releasing factor in adult male and female rats.
Wakabayashi I; Hatano H; Minami S; Tonegawa Y; Akira S; Sugihara H; Ling NC
Brain Res; 1986 May; 372(2):361-5. PubMed ID: 3085872
[TBL] [Abstract][Full Text] [Related]
37. GHRF causes biphasic stimulation of SRIF secretion from rat hypothalamic cells.
Richardson S; Twente S; Audhya T
Am J Physiol; 1988 Dec; 255(6 Pt 1):E829-32. PubMed ID: 2904766
[TBL] [Abstract][Full Text] [Related]
38. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
[TBL] [Abstract][Full Text] [Related]
39. Ectopic growth hormone-releasing factor stimulates growth hormone secretion in the urethane-anesthetized rat in vivo.
Szabo M; Dudlak D; Thominet JL; Frohman LA
Neuroendocrinology; 1983 Nov; 37(5):328-31. PubMed ID: 6417554
[TBL] [Abstract][Full Text] [Related]
40. Noradrenergic modulation of human pancreatic growth hormone-releasing factor (hpGHRF1-44)-induced growth hormone release in conscious male rabbits: involvement of endogenous somatostatin.
Chihara K; Minamitani N; Kaji H; Kodama H; Kita T; Fujita T
Endocrinology; 1984 Apr; 114(4):1402-6. PubMed ID: 6142818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
